Merck says test drug molnupiravir cuts most exceedingly awful impacts of COVID-19

The Pill Study followed 775 grown-ups with gentle to-direct COVID-19 thought about higher danger for extreme infection. Merck & Co. said Friday that its experimental COVID-19 pill reduced hospitalizations and deaths by half in people recently infected with the coronavirus and that it would soon ask health officials in the U.S. and around the world … Continue reading Merck says test drug molnupiravir cuts most exceedingly awful impacts of COVID-19